
Clarisa Blattner: Could Medicare LCD Policy Be Poised for Reform?
Details behind the proposed Timely Access to Coverage Decisions Act

Details behind the proposed Timely Access to Coverage Decisions Act

Genetic testing now accounts for 43 percent of all Medicare Part B laboratory spending

Cuts to reimbursement rates under PAMA have been pushed back again by Congress, this time to January 2027

However, attorney Danielle Sloane urges labs to be proactive about potential PAMA reporting requirements on Jan. 31 if the bill doesn’t pass quickly

Better clinical laboratory test data reporting would allow ‘Medicare rates to be more appropriately set,’ says Susan Van Meter